Joshua T. Davis is a recent graduate from the Department of Drug Discovery and Development at Auburn University with degrees in biomedical sciences (B.S. Auburn 2013), pharmacy (Pharm.D. Auburn 2017), and pharmaceutics (PhD. 2023). He has experience in transcriptomic and proteomic analysis, flow cytometry, in vivo models, in vitro models, pharmacokinetics, and drug resistance. He also has a background in pharmacy with experiences at CVS and the Central Alabama VA Medical Center in Montgomery. He is currently interested in designing oncologic model systems to better identify drugs with high clinical potential and is interested in utilizing state of the art transcriptomic, genomic, and proteomic techniques to better understand how treatments affect remaining cancer cell populations to help prevent and treat resistance. He is also interested in immunologic treatments, treatments using DNA repair, and treatments targeting the tumor microenvironment and tumor heterogeneity. He is a member of AACR, Rho Chi, Phi Kappa Phi, and Kappa Psi.
Joshua T. Davis is a recent graduate from the Department of Drug Discovery and Development at Auburn University with degrees in biomedical sciences (B.S. Auburn 2013), pharmacy (Pharm.D. Auburn 2017), and pharmaceutics (PhD. 2023). He has experience in transcriptomic and proteomic analysis, flow cytometry, in vivo models, in vitro models, pharmacokinetics, and drug resistance. He also has a background in pharmacy with experiences at CVS and the Central Alabama VA Medical Center in Montgomery. He is currently interested in designing oncologic model systems to better identify drugs with high clinical potential and is interested in utilizing state of the art transcriptomic, genomic, and proteomic techniques to better understand how treatments affect remaining cancer cell populations to help prevent and treat resistance. He is also interested in immunologic treatments, treatments using DNA repair, and treatments targeting the tumor microenvironment and tumor heterogeneity. He is a member of AACR, Rho Chi, Phi Kappa Phi, and Kappa Psi.